Sudden cardiac death: how to prevent it

Czech version

Authors: L. Křivan
Authors‘ workplace: LF MU a FN Brno, pracoviště Bohunice ; Interní kardiologická klinika
Published in: Kardiol Rev Int Med 2006, 8(1-2): 20-24
Category: Editorial

Overview

The article summarizes basic information about etiology and importance of sudden cardiac death in general population. The main topic of the text is the assessment of sudden cardiac death risk as well as a primary prevention of arrhythmic death in particular patients’ groups. Some of the recommendations for prophylactic ICD implantation are also included.

Key words:
sudden cardiac death, primary prevention, implantable cardioverter-defibrillator, malignant arrhythmias

Sources

1. Myerburg R, Castellanos A. Cardiac arrest and sudden cardiac death. In: Zipes DP, Braunwald E (eds). Textbook of Heart Disease. Philadelphia: WB Saunders 2001.

2. Zheng ZJ, Croft JB et al. Sudden Cardiac Death in the United States, 1989 to 1998. Circulation 2001; 104: 2158-2163.

3. Huikuri Heikki V, Castellanos A, Myerburg R. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345:1473-1482.

4. Kozák M. Náhlá srdeční smrt – problém současné kardiologie. Vnitř Lék 2001; 47(9): 634-641.

5. Steinberg JS, Regan A, Sciacca R, Bigger T et al. Predicting arrhythmic events after acute myocardial infarction using the signal averaged electrocardiogram. Am J Cardiol 1992; 69: 13-21.

6. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Eng J Med 2002; 346(12): 877-883.

7. Pitschner HF, Neuzner J, Himmrich E et al. Implantable cardioverter-difibrillator therapy: Influence of left ventricular function on long-term results. J Intervent Card Electrophysiol 1997; 1: 211-220.

8. Moss AJ, Hall WJ, Cannom DS et al for the Multicenter automatic defibrillator implantation trial investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.

9. Ikeda T, Saito H, Tanno K et al. T wave alternans as a predictor for sudden death after myocardial infarction. Am J Cardiol 2002; 89: 79-82.

10. Batchvarov V, Malik M. QT dispersion. In: Malik M, Camm AJ. Dynamic Electrocardiography. Edinburgh: Blackwell Futura 2004: 326-349.

11. Priori S,Aliot E, Blomstrom-Lundquist C et al. Task force of the sudden cardiac death of the European society of cardiology. Eur Heart J 2001; 22: 1374-1450.

12. La Rovere MT, Bigger JT, Marcus FI et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-484.

13. Ghuran A, Reid F, La Rovere MT et al. Heart rate turbulence based predictors of fatal and nonfatal cardiac arrest (the ATRAMI substudy). Am J Cardiol 2002; 89: 184-190.

14. Mitchell LB. The role of the transvenous catheter electrophysiologic study in the evaluation and management of ventricular tachyarrhythmias associated with ischaemic heart disease. CEPR 2002; 6(4): 458-462.

15. Bansch D, Antz M, Boczor S et al. Primary prevention of sudden cardiac death in idipathic dilated cardiomyopathy. The cardiomypathy trial (CAT). Circulation 2002; 105: 1453-1458.

16. Knight BP, Bitar CF, Pelosi F et al. Predictors of mortality in AMIOVIRT: nonischaemic dilated cardiomyopathy and nonsustained ventricular tachycardia. Pacing Clin Electrophysiol 2002; 24(PII): 526.

17. Salukhe T, Francis D, Sutton R. Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker- defibrillators reduce all-cause mortality and hospitaliyation. Int J Cardiol 2003; 87: 119-120.

18. Sander S, Wieselthale G, Zuckermann A et al. Survival benefit of implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001; 104 (Suppl 1): 171-176.

19. Josephson M, Hein J, Wellens J. Implantable defibrillators and sudden cardiac death. Circulation 2004; 109: 2685-2691.

20. Maron BJ. Risk stratification and prevention of sudden deathin hypertrophic cardiomyopathy. Cardiol Rev 2002; 10: 173-181.

21. Saksena S, Madan N. Management of the patient with an implantable cardioverter-difibrillator in the third millennium. Circulation 2002; 106: 2642-2646.

22. Corrado D, Basso Ch, Nava A et al. Arrhythmogenic right ventricular cardiomyopathy: Current diagnostic and management strategies. Cardiol Rev 2001; 9(5): 259-265.

23. Táborský M, Kautzner J, Bytešník J et al. Zásady pro implantace kardiostimulátorů, implantabilních kardioverterů – defibrilátorů a srdeční resynchronizační léčbu (2005). Cor Vasa 2005; 47(9): 59-68.

24. Moss AJ, Zareba W, Hall WJ et al. For the Multicenter Automatic Defibrillator Implantation Trial II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.

25. Wichterle D, Camm AJ, Malik M. Preserved herat rate turbulence slope indentifies low-risk postinfarction patients with left ventricular dysfunction. Interv Akut Kardiol 2006; 5(A): 34.

26. Klingenheben T, Hohnloser S. Usefulness of risk stratification for future cardiac events in infarct survivors with severely depressed versus near normal left ventricular function: results from a prospective long term follow-up study. Ann Noninvasive Electrocardiol 2003 Jan;8(1):68-74.